The NIH has awarded $169 million this year to support 110 new projects in the Brain Research through Advancing Innovative Neurotechnologies Initiative.
The researchers' techniques will enable an understanding of brain circuitry and allow them to study disease models of autism and schizophrenia.
In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.
The team said the resource allows for single-target or combinatorial genetic screens to be carried out at scale in a multiplexed or arrayed format.
In PNAS this week: analytical method for assessing shared variants, treatment targets in hereditary pancreatic cancer, and more.
In Nature this week: improved maize reference genome, and more.
In Cell this week: variants linked to enhanced branching among tomatoes, innate and adaptive immune response to Zostavax vaccination, and more.
Variants affecting Alzheimer's risk, cholesterol levels, and more also affect human longevity, according to a speaker at the Biology of Genomes meeting.
At the Biology of Genomes meeting, University of South Australia's Alicia Byrne described her team's work using sequencing to solve cases of perinatal death.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.